BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38581717)

  • 1. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
    Chen Q; Ouyang L; Liu Q
    Biomol Biomed; 2024 Apr; ():. PubMed ID: 38581717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis of the prognostic and immunological roles of
    Liu S; Liu Y; Zhang X; Song X; Zhang B; Zhang Y
    Front Genet; 2022; 13():1039440. PubMed ID: 36313454
    [No Abstract]   [Full Text] [Related]  

  • 3. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
    Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
    Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pancancer analysis of histone deacetylase 3 in human tumors.
    Chen H; Xu F; Qin A; Guo S; Zhang G; Yu B; Zheng Q
    Transl Cancer Res; 2024 Jan; 13(1):65-80. PubMed ID: 38410236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of the prognostic and immunological role of
    Tan Y; Meng W; Jiang Z; Li N; Zhang T; Zhang J; Ma L; Guan Y
    Transl Cancer Res; 2024 Feb; 13(2):1091-1113. PubMed ID: 38482441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NALCN is a potential biomarker and therapeutic target in human cancers.
    He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y
    Front Genet; 2023; 14():1164707. PubMed ID: 37152978
    [No Abstract]   [Full Text] [Related]  

  • 7. Pan-cancer Multi-omics Analysis Reveals HMGN1 as a Potential Prognostic and Immune Infiltration-associated Biomarker.
    Guo Y; Zhang R; Xu H; Hong K; Cen K; Mai Y; Wu Z
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38310387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
    Ning Y; Li Y; Wang H
    Front Genet; 2023; 14():1108167. PubMed ID: 36713082
    [No Abstract]   [Full Text] [Related]  

  • 9. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
    Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
    J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
    Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
    Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors.
    Dai P; Xiong L; Wei Y; Wei X; Zhou X; Zhao J; Tang H
    Sci Rep; 2023 Sep; 13(1):16226. PubMed ID: 37758792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic analysis of
    Jiang Y; Wang X; Li L; He J; Jin Q; Long D; Liu C; Zhou W; Liu K
    Front Genet; 2022; 13():926943. PubMed ID: 35991552
    [No Abstract]   [Full Text] [Related]  

  • 16. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
    Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
    Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
    Yang W; Liu Z; Liu T
    Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
    Huang S; Dong C; Li D; Xu Y; Wu J
    Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
    [No Abstract]   [Full Text] [Related]  

  • 20. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
    Fu H; Li K; Wang S; Li Y
    Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.